Spots Global Cancer Trial Database for kaposi sarcoma
Every month we try and update this database with for kaposi sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) | NCT03157167 | Kaposi Sarcoma HIV Infections | Tc99m-tilmanoce... | 18 Years - | Navidea Biopharmaceuticals | |
| Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma | NCT03469804 | Kaposi Sarcoma Progression, Di... | Pembrolizumab | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia | NCT04534127 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Retreatment With Intratumoral Diffusing Alpha Radiation Emitters | NCT04540588 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery | NCT02408861 | Advanced Malign... Anal Carcinoma HIV Infection Kaposi Sarcoma Lung Carcinoma Metastatic Mali... Recurrent Class... Refractory Clas... Unresectable So... | Biospecimen Col... Bone Marrow Bio... Computed Tomogr... Ipilimumab Nivolumab Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) | NCT06004011 | Cervical Cancer Kaposi Sarcoma Non Hodgkin Lym... | ARROW strategie... One-time educat... | 15 Years - 39 Years | Implenomics | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) | NCT03157167 | Kaposi Sarcoma HIV Infections | Tc99m-tilmanoce... | 18 Years - | Navidea Biopharmaceuticals | |
| NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | NCT04893018 | AIDS-Related Ka... HIV Infection Kaposi Sarcoma | Efineptakin alf... | 18 Years - | Fred Hutchinson Cancer Center | |
| Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity | NCT01296815 | Kaposi´s Sarcom... | Bevacizumab | 18 Years - 60 Years | Centro de Investigación en. Enfermedades Infecciosas, Mexico | |
| Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi | NCT03160183 | Kaposi Sarcoma HIV | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | ||
| Development of Serologic Assays for Human Herpes Virus-8 | NCT00395278 | Kaposi Sarcoma HIV Infection | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma | NCT01412515 | Kaposi Sarcoma | everolimus | 18 Years - | Institut National de la Santé Et de la Recherche Médicale, France | |
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma | NCT02659930 | Kaposi Sarcoma | liposomal doxor... pomalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
| Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma | NCT04065152 | Kaposi Sarcoma | Talimogene lahe... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| HHV8 and Solid Organ Transplantation | NCT05081141 | HHV8 HHV8 Infection HHV8-Related Ma... Kaposi Sarcoma Lung Transplant... Liver Transplan... Kidney Transpla... Castleman Disea... | Diagnostic test... | 18 Years - | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | |
| Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma | NCT04941274 | Kaposi Sarcoma | Abemaciclib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of Propranolol to Treat Kaposi Sarcoma | NCT05797662 | Kaposi Sarcoma | Propranolol | - | AIDS Malignancy Consortium | |
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer | NCT02595866 | AIDS-Related No... Clinical Stage ... Clinical Stage ... Hepatocellular ... HIV Infection Kaposi Sarcoma Locally Advance... Locally Advance... Metastatic Lung... Metastatic Mali... Metastatic Mela... Non-Hodgkin Lym... Recurrent Class... Recurrent Malig... Refractory Clas... Refractory Mali... Stage III Lung ... Stage IV Lung C... Unresectable Me... | Antiretroviral ... Biopsy Biospecimen Col... Computed Tomogr... Pembrolizumab Positron Emissi... | 18 Years - | National Cancer Institute (NCI) | |
| Natural History Study of Kaposi Sarcoma | NCT06375122 | Kaposi Sarcoma HIV | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT) | NCT03886181 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Device: Radiati... | 18 Years - | Alpha Tau Medical LTD. | |
| Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC | NCT05510908 | HIV-Associated ... HIV Infections Cancer AIDS Related Ly... AIDS-related Ka... AIDS-Related Ma... Anal Cancer HPV-Related Mal... | Non-Interventio... Non-Interventio... | 18 Years - | AIDS Malignancy Consortium | |
| NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma | NCT04303117 | Kaposi Sarcoma | NHS-IL12 M7824 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT) | NCT03737734 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma | NCT04303117 | Kaposi Sarcoma | NHS-IL12 M7824 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) | NCT06004011 | Cervical Cancer Kaposi Sarcoma Non Hodgkin Lym... | ARROW strategie... One-time educat... | 15 Years - 39 Years | Implenomics | |
| Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions | NCT00026793 | Kaposi's Sarcom... | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia. | NCT03889899 | Skin Cancer Mucosal Neoplas... Soft Tissue Neo... | Radiation: Diff... | 18 Years - | Alpha Tau Medical LTD. | |
| Trial of Ixazomib for Kaposi Sarcoma | NCT04305691 | Kaposi Sarcoma Skin | Ixazomib Citrat... Quality-of-Life... Questionnaire A... | 18 Years - | AIDS Malignancy Consortium | |
| Risk Factors for Non-HIV-Related Kaposi s Sarcoma | NCT00339326 | Kaposi's Sarcom... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Study of sEphB4-HSA in Kaposi Sarcoma | NCT03993106 | Kaposi Sarcoma | sEphB4-HSA | 18 Years - | Vasgene Therapeutics, Inc | |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma | NCT05411237 | Kaposi Sarcoma HIV-1-infection AIDS-related Ka... | Pegylated lipos... Paclitaxel | 18 Years - | AIDS Malignancy Consortium | |
| Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma | NCT03050788 | Kaposi Sarcoma | Smartphone conf... | 18 Years - | Massachusetts General Hospital | |
| An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) | NCT03157167 | Kaposi Sarcoma HIV Infections | Tc99m-tilmanoce... | 18 Years - | Navidea Biopharmaceuticals | |
| Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma | NCT04941274 | Kaposi Sarcoma | Abemaciclib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients | NCT00055237 | Kaposi's Sarcom... HIV Infections HIV Seronegativ... | Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis | NCT04742387 | Kaposi Sarcoma KSHV Associated... Primary Effusio... IL-6 Related KS... | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
